Vanderbilt-Ingram Cancer Center

Publications

• Linkous, AG, Yazlovitskaya, EM Novel radiosensitizing anticancer therapeutics. Anticancer Res, 32(7), 2487-99, 2012.
• Schleicher, SM, Thotala, DK, Linkous, AG, Hu, R, Leahy, KM, Yazlovitskaya, EM, Hallahan, DE Autotaxin and LPA receptors represent potential molecular targets for the radiosensitization of murine glioma through effects on tumor vasculature. PLoS One, 6(7), e22182, 2011.
• Schulte, RR, Linkous, AG, Hallahan, DE, Yazlovitskaya, EM Cytosolic phospholipase A2 as a molecular target for the radiosensitization of ovarian cancer. Cancer Lett, 304(2), 137-43, 2011.
• Thotala, DK, Geng, L, Dickey, AK, Hallahan, DE, Yazlovitskaya, EM A new class of molecular targeted radioprotectors: GSK-3beta inhibitors. Int J Radiat Oncol Biol Phys, 76(2), 557-65, 2010.
• Linkous, A, Geng, L, Lyshchik, A, Hallahan, DE, Yazlovitskaya, EM Cytosolic phospholipase A2: targeting cancer through the tumor vasculature. Clin Cancer Res, 15(5), 1635-44, 2009.
• Kobayashi, H, Yazlovitskaya, EM, Lin, PC Interleukin-32 positively regulates radiation-induced vascular inflammation. Int J Radiat Oncol Biol Phys, 74(5), 1573-9, 2009.
• Yazlovitskaya, EM, Linkous, AG, Thotala, DK, Cuneo, KC, Hallahan, DE Cytosolic phospholipase A2 regulates viability of irradiated vascular endothelium. Cell Death Differ, 15(10), 1641-53, 2008.
• Thotala, DK, Hallahan, DE, Yazlovitskaya, EM Inhibition of glycogen synthase kinase 3 beta attenuates neurocognitive dysfunction resulting from cranial irradiation. Cancer Res, 68(14), 5859-68, 2008.
• Yazlovitskaya, EM, Edwards, E, Thotala, D, Fu, A, Osusky, KL, Whetsell, WO, Boone, B, Shinohara, ET, Hallahan, DE Lithium treatment prevents neurocognitive deficit resulting from cranial irradiation. Cancer Res, 66(23), 11179-86, 2006.
• Tan, J, Geng, L, Yazlovitskaya, EM, Hallahan, DE Protein kinase B/Akt-dependent phosphorylation of glycogen synthase kinase-3beta in irradiated vascular endothelium. Cancer Res, 66(4), 2320-7, 2006.